Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
[1] Patients with pre-existing conditions such as gastroparesis, functional dyspepsia, or irritable bowel syndrome may experience more pronounced or prolonged symptoms
:max_bytes(150000):strip_icc()/GettyImages-2144475445-fcdc8d81403a42d99a7d568034d1ac90.jpg)
The weekly dosing schedule remains consistent whether you inject Monday morning before eating or Thursday evening after dinner
The SURPASS trials demonstrated stable or improved kidney function in the tirzepatide groups compared to placebo, suggesting long-term kidney benefits that outweigh the short-term risks from GI-related dehydration
Note that the semaglutide dose in SURPASS-2 was 1 mg (not the 2 mg diabetes dose or 2.4 mg obesity dose), so these comparisons don't represent maximal semaglutide
US$ 27.54
US$ 28.35
US$ 24.72
US$ 23.74
US$ 23.15
US$ 27.48
US$ 23.54
US$ 29.29
US$ 20.50
